From: A single-center study of clinical features of pediatric Sjögren’s syndrome
No.(n = 54) | pSS (n = 34) | sSS (n = 20) | P-value | |
---|---|---|---|---|
Age at diagnosis (mean ± SD) | 10.2 ± 2.6 | 10.0 ± 2.706 | 10.6 ± 2.4 | 0.416 |
Age at first sign/symptom (mean ± SD) | 9.9 ± 2.6 | 9.7 ± 2.8 | 10.3 ± 2.3 | 0.383 |
Female: male ratio (%) | 49:5(90.7) | 32:2(94.1) | 17:3(85.0) | 0.347* |
Dry mouth (%) | 7(13.0) | 2(5.9) | 5(25.0) | 0.087* |
Dry eyes (%) | 5(9.3) | 3(8.8) | 2(10.0) | 1.000* |
Fever (%) | 29(53.7) | 19(55.9) | 10(50.0) | 0.780* |
Skin involvement (%) | 25(46.3) | 14(41.2) | 11(55.0) | 0.325 |
Arthralgia (%) | 13(24.1) | 4(11.8) | 9(45.0) | 0.009* |
Arthritis (%) | 7(13.0) | 2(5.9) | 5(25.0) | 0.087* |
Fatigue (%) | 6(11.1) | 4(11.8) | 2(10.0) | 1.000* |
Glandular enlargement (%) | 2(3.7) | 1(2.9) | 1(5.0) | 1.000* |
Peripheral lymphadenopathies (%) | 21(38.9) | 14(41.2%) | 7(35.0) | 0.653 |
Cytopenias (%) | 16(29.6) | 11(32.4) | 5(25.0) | 0.568 |
RTA (%) | 5(9.3) | 5(14.7) | 0(0.0) | 0.145* |
Myalgias (%) | 6(11.1) | 5(14.7) | 1(5.0) | 0.395* |